Last reviewed · How we verify
Expanded Access to Velmanase Alfa
NCT04959240
AVAILABLE
Individual patient expanded access requests may be considered for patients who have no other treatment options.
Details
| Lead sponsor | Chiesi Farmaceutici S.p.A. |
|---|
| Status | AVAILABLE |
|---|
Conditions
Interventions